Abstract: RANTES mutants characterised by the substitution or addition of amino acids at the N-terminal of RANTES wild-type sequence and in the N-loop and/or 40's loop regions of RANTES wild-type sequence, and their use as anti-HIV, anti-allergic or anti-inflammatory agents.
Type:
Application
Filed:
March 28, 2003
Publication date:
November 20, 2003
Applicant:
FONDAZIONE CENTRO SAN RAFFAELLE DEL MONTE TABOR